Bristol-Myers releases mixed Opdivo lung cancer results - CNBC

Bristol-Myers releases mixed Opdivo lung cancer results  CNBC

Bristol-Myers released mixed results on Wednesday from trials testing the survival benefit of its immunotherapy Opdivo in combination with either chemotherapy ...